Investors can lead Dun & Bradstreet securities fraud lawsuit

Rosen Law Firm, an international investor rights law firm, is informing investors who sold Dun & Bradstreet Holdings, Inc. (DNB) stock or participated in its merger that they may have grounds to join a securities fraud class action lawsuit. The suit alleges that the company and its executives made materially false and misleading statements and omissions regarding the company's merger.

The lawsuit, filed on September 25, 2026, claims that DNB's merger announcement on March 23, 2025, and its proxy statement filed on May 13, 2025, misled investors about the company's true value and the transaction itself. Specifically, the complaint alleges that the merger was presented as the result of an ordinary strategic review, while executive chairman Foley allegedly had a personal interest in a swift sale. The suit also claims that superior valuation alternatives from Bank of America Securities were omitted.

Rosen Law Firm reminds investors who sold DNB common stock between May 13, 2025, and August 26, 2025, or who held shares as of May 9, 2025, and were impacted by the merger finalized on August 26, 2025, at $9.15 per share, that they may be entitled to compensation without out-of-pocket costs. The deadline to seek appointment as lead plaintiff is November 10, 2026.

The firm emphasizes the importance of selecting experienced counsel in securities litigation. Rosen Law Firm states it has a history of recovering substantial amounts for investors in similar cases. While a class has not yet been certified, investors can choose to participate or remain as absent class members.